comparemela.com

Latest Breaking News On - Christian morath - Page 1 : comparemela.com

TolerogenixX expands Phase II immune-tolerance trial and closes EUR 12 million Series A financing

Ongoing Phase IIb study expands to arm B5-year results of phase I study confirm efficacy and safety of novel immune-tolerance inducing cell therapy in organ transplantationSecond closing of Series A

Baden wübergNeu ulmChristian morathInes regina buthMatthias schaierDietrich bruchmannNeuenheimer feldHeidelberg university hospitalDb speciality gmbh coOngoing phaseTolerogenixx gmbhSafety boardHeidelberg universityBiotech mountainsCoinvest corporte finance gmbh

Covid-vaccinated kidney transplant recipients are especially vulnerable to emerging Covid variants

Highlight New research indicates that many kidney transplant recipients may not be adequately protected against emerging SARS-CoV-2 variants with the

Baden wübergUnited statesAsa hidmarkMarvin reinekeDietmar hopp stiftungLouise benningRalf bartenschlagerGerald ponathClaudius speerChristian nusshagKatrin kleinMatthias schaierJulia grenzMarie bartenschlagerMartin zeierChristian morath

vimarsana © 2020. All Rights Reserved.